Phase II Amount
$1,499,495
Our ability to rapidly respond to new chemical and biological threats is limited by a lack of facilities, personnel, and equipment able to conduct precision molecular analysis. We can remove this bottleneck by deploying a protective network of new automated, high performance surveillance equipment around ordinary warfighters and civilians for the first time. Sensitive enough to detect all manner of chemical, biological, radiological, nuclear, and explosive threats at close proximal ranges continuously, our technology can be adapted for placement in buildings, on vehicles, drones, etc. Software enabled, it can be thought of as an anti-virus platform for actual viruses and other threats, alerting first responders and gathering critical intelligence about the combat theater. Our prime end users are the Air Force Research Laboratory, Biosurveillance Unit (Dr. Clarise Starr), The Army Edgewood Chemical Biological Center (Dr. Jason Guicheteau), and the Army Soldier Systems Center (Dr. Andre Senecal). These end-users will use our solution to identify and quantify chemical and biological threats with greater ease and accuracy than previously possible. The three users will make introductions to transition partners with threat detection and biosurveillance needs in all service branches, and law enforcement.
